MedPath

ERIVEDGE

ERIVEDGE

Approved
DIN Number

02409267

Drug Class

Human

Market Date

Aug 9, 2013

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02409267
AIG Number0154490001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XJ01 VISMODEGIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VISMODEGIBActive
Strength: 150 MG
Monograph: VISMODEGIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.